Skip to main content
OpenTrials
Completed

NCT Number: NCT03455101

Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus

This study evaluates the overall cardiovascular risk status and best predictors of optimal metabolic control of Turkish adult patients with diabetes mellitus.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Gulhane School of Medicine Department of Endocrinology and Metabolism

Ankara, 06018, Turkey (Türkiye)

About this study

Diabetes mellitus is one of the most common chronic diseases with an increasing prevalence worldwide.The prevalence of diabetes is also increased significantly in Turkey, from 7.2 % in 2002 to 13.7% in 2012.This increasing prevalence leads to serious public health problems and a significant economic burden. Therefore, the optimal treatment of diabetes and prevention of diabetic complications, especially the cardiovascular outcomes, is utmost important. Although achieving glycemic targets in patients with diabetes is of great importance, blood glucose is not the only predictor of cardiovascular outcome in diabetes. Optimization of other metabolic parameters such as lipids, arterial blood pressure (ABP), and body weight as well as a healthy lifestyle are utmost important. As there is hardly enough data about glycemic and other metabolic control parameters in Turkish adult patients with type 1 or type 2 diabetes, this nationwide survey was performed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with type 1 or type 2 diabetes
  • Upper than 18 years old
  • To be under follow-up in the same center for at least one year.

Exclusion criteria

  • Pregnancy
  • Younger than 18 years old,
  • History of decompensated liver disease,
  • History of psychiatric disorders interfering cognition or compliance
  • History of bariatric surgery
  • History of renal replacement therapy.

Treatment and study plan

There is no intervention.

Other

There is no intervention.

Primary outcomes

  1. Glycemia control status of Turkish adult patients with diabetes mellitus

    Time frame: 7 days

    Glycemia control will be defined as good control if the mean HbA1c level of patients < 7% or poor control if the mean HbA1c level of patient > 7%

Secondary outcomes

  1. Blood pressure control status of Turkish adult patients with diabetes mellitus

    Time frame: 7 days

    Home blood pressure <135/85 mmHg will be defined as under control.

  2. Lipid control status of Turkish adult patients with diabetes mellitus.

    Time frame: 7 days.

    Triglyceride < 150 mg/dl, LDL-C < 100 mg/dl, HDL-C > 40 mg/dl for men, and HDL-C > 50 mg/dl for women will be defined as under control.

  3. Weight control status of Turkish adult patients with diabetes mellitus.

    Time frame: 7 days.

    Body mass index < 30 kg/m2 will be defined as under control. Weight and height will be combined to report body mass index in kg/m2.

Sponsors and collaborators

Lead sponsor

Gulhane School of Medicine

Other

Registry information

Official study title

Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus (TEMD Study)

Acronym: TEMD

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Mar 6, 2018
Registry last updated
Mar 6, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.